Trastuzumab Rezetecan
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Trastuzumab Rezetecan, covering 2025-07-02 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer [Phase 2]